| Issue Date | Title | Author(s) |
| 1987-01-01 | A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma: An ECOG study | Falkson, G; Ryan, LM; Johnson, LA; Simson, IW; Coetzer, BJ; Carbone, PP; Creech, RH; Schutt, AJ |
| 2018-03-01 | Evaluation of the impact of a personalized postdonation short messaging service on the retention of whole blood donors | Gemelli, CN; Carver, A; Garn, A; Wright, ST; Davison, TE |
| 2018-01-01 | Measurement of active and sedentary behavior in context of large epidemiologic studies | Matthews, CE; Keadle, SK; Moore, SC; Schoeller, DS; Carroll, RJ; Troiano, RP; Sampson, JN |
| 1999-08-19 | Paraoxonase polymorphism and its effect on male reproductive outcomes among Chinese pesticide factory workers | Padungtod, C; Niu, T; Wang, Z; Savitz, DA; Christiani, DC; Ryan, LM; Xu, X |
| 2001-01-01 | A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes | Scott, LJ; Warram, JH; Hanna, LS; Laffel, LMB; Ryan, L; Krolewski, AS |
| 2013-01 | Best worst discrete choice experiments in health: methods and an application. | Lancsar, E; Louviere, J; Donaldson, C; Currie, G; Burgess, L |
| 1994-01-01 | Anticonvulsant teratogenesis: 2. Statistical methods for multiple birth outcomes | Legler, JM; Ryan, LM; Harvey, EA; Holmes, LB |
| 1998-12-01 | PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinoma | Witte, RS; Ryan, LM; Schutt, AJ; Carbone, PP; Engstrom, PF |
| 2015-12-01 | Understanding physical developer (PD): Part I - Is PD targeting lipids? | de la Hunty, M; Moret, S; Chadwick, S; Lennard, C; Spindler, X; Roux, C |
| 1992-01-01 | Phase II Trials of Interferons-α and -β in Advanced Sarcomas | Borden, EC; Kim, K; Ryan, L; Blum, RH; Shiraki, M; Tormey, DC; Comis, RL; Hahn, RG; Parkinson, DR |
